NO880802L - Mellomprodukter og fremgangsmaater til fremstilling av antihyperkolesterolemiske tetrazolforbindelser. - Google Patents

Mellomprodukter og fremgangsmaater til fremstilling av antihyperkolesterolemiske tetrazolforbindelser.

Info

Publication number
NO880802L
NO880802L NO88880802A NO880802A NO880802L NO 880802 L NO880802 L NO 880802L NO 88880802 A NO88880802 A NO 88880802A NO 880802 A NO880802 A NO 880802A NO 880802 L NO880802 L NO 880802L
Authority
NO
Norway
Prior art keywords
hypercolesterolemic
tetrazolic
intermediates
procedures
compounds
Prior art date
Application number
NO88880802A
Other languages
English (en)
Other versions
NO880802D0 (no
NO178432C (no
NO178432B (no
Inventor
John J Wright
Sing-Yuen Sit
Neelakantan Balasubramaian
Peter J Brown
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO880802D0 publication Critical patent/NO880802D0/no
Publication of NO880802L publication Critical patent/NO880802L/no
Priority to NO924942A priority Critical patent/NO178190C/no
Priority to NO924941A priority patent/NO179207C/no
Priority to NO942083A priority patent/NO178767C/no
Publication of NO178432B publication Critical patent/NO178432B/no
Publication of NO178432C publication Critical patent/NO178432C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO880802A 1987-02-25 1988-02-24 Tetrazolmellomprodukt NO178432C (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO924942A NO178190C (no) 1987-02-25 1992-12-21 3,3-bis-(eventuelt substituert)-fenyl-2-(1-metyl-1H-tetrazol-5-yl)-1-propenal
NO924941A NO179207C (no) 1987-02-25 1992-12-21 Analogifremgangsmåte til fremstilling av en terapeutisk aktiv forbindelse
NO942083A NO178767C (no) 1987-02-25 1994-06-06 Tetrazolmellomprodukt og fremgangsmåte til fremstilling derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (4)

Publication Number Publication Date
NO880802D0 NO880802D0 (no) 1988-02-24
NO880802L true NO880802L (no) 1988-08-26
NO178432B NO178432B (no) 1995-12-18
NO178432C NO178432C (no) 1996-03-27

Family

ID=26691250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880802A NO178432C (no) 1987-02-25 1988-02-24 Tetrazolmellomprodukt

Country Status (27)

Country Link
US (1) US4898949A (no)
JP (1) JP2603284B2 (no)
KR (1) KR960007167B1 (no)
CN (1) CN1030077C (no)
AT (1) AT395588B (no)
AU (1) AU610562B2 (no)
BE (1) BE1002115A3 (no)
CA (1) CA1328269C (no)
CH (1) CH678182A5 (no)
DE (1) DE3805789C2 (no)
DK (2) DK97388A (no)
ES (1) ES2009547A6 (no)
FI (1) FI96600C (no)
FR (1) FR2611201B1 (no)
GB (1) GB2202845B (no)
GR (1) GR1000473B (no)
HU (3) HU201532B (no)
IE (1) IE61608B1 (no)
IT (1) IT1216752B (no)
LU (1) LU87143A1 (no)
MY (1) MY102290A (no)
NL (1) NL8800468A (no)
NO (1) NO178432C (no)
NZ (1) NZ223621A (no)
PT (1) PT86821B (no)
SE (3) SE504553C2 (no)
YU (1) YU46781B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
JP2001526256A (ja) * 1997-12-19 2001-12-18 ワーナー−ランバート・エクスポート・リミテッド １，３−ジオールの合成方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
EP0117228B1 (en) * 1983-01-24 1986-11-05 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
KR890001651B1 (ko) * 1984-06-22 1989-05-12 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 피라졸 동족체 및 이의 유도체의 제조방법
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Also Published As

Publication number Publication date
CN1070642A (zh) 1993-04-07
MY102290A (en) 1992-05-15
YU36488A (en) 1990-02-28
JP2603284B2 (ja) 1997-04-23
SE512485C2 (sv) 2000-03-20
SE9300976D0 (sv) 1993-03-24
SE503201C2 (sv) 1996-04-15
AU610562B2 (en) 1991-05-23
FR2611201A1 (fr) 1988-08-26
HU895124D0 (no) 1990-01-28
FI880868A0 (fi) 1988-02-24
DK97388A (da) 1988-08-26
FI96600B (fi) 1996-04-15
NO880802D0 (no) 1988-02-24
NO178432C (no) 1996-03-27
YU46781B (sh) 1994-05-10
DE3805789A1 (de) 1988-09-15
IE61608B1 (en) 1994-11-16
GR880100100A (en) 1988-12-16
DE3805789C2 (de) 2001-05-31
IT1216752B (it) 1990-03-08
HU201533B (en) 1990-11-28
PT86821B (pt) 1992-05-29
NL8800468A (nl) 1988-09-16
IT8819526A0 (it) 1988-02-24
FR2611201B1 (fr) 1991-01-11
ES2009547A6 (es) 1989-10-01
GB8804281D0 (en) 1988-03-23
GB2202845A (en) 1988-10-05
ATA46088A (de) 1992-06-15
SE9300977L (no)
BE1002115A3 (fr) 1990-07-10
GB2202845B (en) 1991-05-22
DK97388D0 (da) 1988-02-24
HU201534B (en) 1990-11-28
SE9300977D0 (sv) 1993-03-24
FI96600C (fi) 1996-07-25
DK113897A (da) 1997-10-06
HUT47258A (en) 1989-02-28
PT86821A (pt) 1988-03-01
SE8800637D0 (sv) 1988-02-24
KR880009946A (ko) 1988-10-06
NZ223621A (en) 1991-06-25
GR1000473B (el) 1992-07-30
SE9300976L (no) 1993-03-24
AT395588B (de) 1993-01-25
IE880502L (en) 1988-08-18
CA1328269C (en) 1994-04-05
AU1213288A (en) 1988-09-01
CN1030077C (zh) 1995-10-18
LU87143A1 (fr) 1988-09-20
NO178432B (no) 1995-12-18
FI880868A (fi) 1988-08-26
KR960007167B1 (ko) 1996-05-29
JPS63290872A (ja) 1988-11-28
SE8800637L (sv) 1988-08-26
CH678182A5 (no) 1991-08-15
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
HU201532B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
NO882762L (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
NO880262L (no) Fremgangsmaate for fremstilling av b avermectiner.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO890661D0 (no) Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO883145D0 (no) Fremgangsmaate til fremstilling av tienoimidazolderivater.
NO170022C (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO882730L (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO863389D0 (no) Fremgangsmaate til fremstilling av substituerte toluidiner.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO880802D0 (no) Mellomprodukter og fremgangsmaater til fremstilling av antihyperkolesterolemiske tetrazolforbindelser.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
DK106589A (da) Fremgangsmaade til fremstilling af aenaturligtae methylanthranilat
NO880106L (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO880834L (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO863604D0 (no) Fremgangsmaate til fremstilling av ferroborlegeringer.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO904825L (no) Mellomprodukter for fremstilling av imidazopyridaziner.
NO890375L (no) Fremgangsmaate for fremstilling av heksanitrostilben.
NO880844D0 (no) Fremgangsmaate for fremstilling av cytotoksiner.
NO924941L (no) Fremgangsmaate til fremstilling av antihyperkolesteromisketetrazolforbindelser
NO913089L (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO884064L (no) Fremgangsmaate for fremstilling av monodispergerte bariumholdige ferritter.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees